courtesy of AOL, IncHeading into the fourth quarter of this year, investors who have been long the stock market are poised for the best gains since the market exploded off the lows…
Jon OggA new earnings season has started, and stocks and bonds are dealing with a likely patch for the government shutdown and the debt ceiling. So which are the stocks to buy…
ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown and impending debt ceiling weighed heavily on biotech stocks. Credit Suisse’s Vamil…
ThinkstockThe number of companies paying dividends in the S&P 500 is at a 15-year high. According to FactSet, just over 80 companies in the index do not pay dividends. Paying dividends has…
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top companies…
ThinkstockThe second-quarter earnings parade has all but come to a end. One conclusion that is painfully obvious to the equity strategy team at Credit Suisse is that many companies beat earnings only…
courtesy of Sprint Corp.In the past 30 years, the hedge fund industry has shown phenomenal growth. Initially formed as true “hedges” against conventional investing, they morphed into vehicles for hedge fund portfolio…
ThinkstockIntrexon Corp. has filed its paperwork with the Securities and Exchange Commission to allow the company to come public in an initial public offering. No formal financial terms have been set for…
Jon C. Ogg These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, May 28, 2013. They include Eli Lilly, W.R. Grace, Intelsat and GlaxoSmithKline.
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to…
Wikimedia CommonsYesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to patients is a genuinely ground-breaking deal. The big drug companies like Pfizer,…
ThinkstockNow that Pfizer Inc. (NYSE: PFE) has started to sell Viagra online at Viagra.com, can Cialis.com and Levitra.com be far behind? These two other drugs face the same black market trouble Viagra…
ThinkstockThe world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States alone. Some…
courtesy of Facebook Inc.Martha Stewart Omnimedia Inc. (NYSE: MSO) is unable to get a court to dismiss charges by Macy’s Inc. (NYSE: M) that it has exclusive rights to some of her…
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a…
